Furthermore, knock down of MAPK1 or MAPK14 with two respective specific siRNAs did not significantly affect IL‐17‐induced resistance toward chemoradiotherapy in three tested cervical cancer cells (Fig. S3BC). Here, IL17A is linked to cervical cancer.